Business

SPARK Europe Webinar Series 2023

26.05.2023

SPARK Europe invites you to our next webinar on new Clinical Trials Regulation which was implemented on 31th of January 2022 and we are in the three-year transition period now. All initial clinical trials applications must be submitted through Clinical Trial Information System (CTIS). We will present our first experiences. What other changes have been brought and which of them relate to the early-phase trials? Our guests will be: Lenka Součková, Pharm.D., D. - a European ...

SPARK Europe Education Webinars

31.03.2023

How to select the right first indication for your platform technology? 12 April 2023 | 16-17 CET | Peter Nestorov, PhD SPARK Europe invites you to our next webinar organized by ...

License agreement between Nencki Institute and Teldoc Sp. z o. o.

03.09.2021

On August 31, 2021, prof. Agnieszka Dobrzyn, Nencki Institute’s Director, and Ms. Marta Kaleńska-Jaśkiewicz, Chief Executive Officer of Teldoc Sp. z o. o., signed a license agreement that defines ...

European patent granted for an invention from Nencki Institute and IIMCB

20.08.2021

The European Patent Office has issued a decision to grant a patent for an invention entitled “microRNA biomarkers in blood for diagnosis of Alzheimer's Disease” (EP3449009). The document claims a ...

Collaboration Agreement between Nencki Institute and Thereson S.r.l.

09.07.2021

Nencki Institute PAS has entered a research collaboration with Thereson, a company focusing on therapeutic magnetic resonance. Laboratory of Mitochondrial Biology and Metabolism, led by ...